APTEVO THERAPEUTICS INC

Historical 13F Holders

Reported Value, Excluding Options

Total Filings

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 03835L405 since 12/18/2024, newest first.

Filer	% of Class	Shares	Form	Filed
Ayrton Capital LLC 13G	10.0%	358,150	13G	8/13/2025 Event 6/30/2025
Ayrton Capital LLC	10.0%	358,150
Alto Opportunity Master Fund, SPC - Segregated Master Portfolio B	10.0%	358,150
Waqas Khatri	10.0%	358,150
Intracoastal Capital LLC 13G	0%	0	13G	6/25/2025 Event 6/18/2025
Mitchell P. Kopin	0%	0
Daniel B. Asher	0%	0
Intracoastal Capital LLC	0%	0
Intracoastal Capital LLC 13G	0%	0	13G	4/25/2025 Event 4/21/2025
Mitchell P. Kopin	0%	0
Daniel B. Asher	0%	0
Intracoastal Capital LLC	0%	0
CVI Investments, Inc. 13G	6.2%	200,000	13G	4/10/2025 Event 4/3/2025
CVI Investments, Inc.	6.2%	200,000
Heights Capital Management, Inc.	6.2%	200,000
Intracoastal Capital LLC 13G	0%	0	13G	4/9/2025 Event 4/3/2025
Mitchell P. Kopin	0%	0
Daniel B. Asher	0%	0
Intracoastal Capital LLC	0%	0
Hudson Bay Capital Management LP 13G/A Amendment 2	4.99%	76,598	13G/A Amendment 2	2/10/2025 Event 12/31/2024
Hudson Bay Capital Management LP	4.99%	76,598
Sander Gerber	4.99%	76,598
Hudson Bay Capital Management LP 13G/A Amendment 1	4.99%	76,598	13G/A Amendment 1	2/10/2025 Event 12/31/2024

Period	Filings	Shares, Excl. Options	Value, Excl. Options	Options Value
2025 Q2	1	10.0 k	$30.5 k	$0
2025 Q1	9	19.6 k	$22.8 k	$0
2024 Q4	14	48.5 k	$209 k	$0